GLP-1 Medications

ADA 85th Scientific Sessions Summary Featuring Mark A. Atkinson, PhD, Chairperson 85th Scientific Sessions Planning Committee and John Buse, MD, PhD, Director, UNC Diabetes Care Center

Conference KOL Highlights

ADA 85th Scientific Sessions Summary Featuring Mark A. Atkinson, PhD, Chairperson 85th Scientific Sessions Planning Committee and John Buse, MD, PhD, Director, UNC Diabetes Care Center

Jun 30, 2025

4 min read

Studies Address Muscle Loss Caused By GLP-1 Drugs

Studies Address Muscle Loss Caused By GLP-1 Drugs

Dennis Thompson

Jun 24, 2025

3 min read

Rival GLP-1 Weight-Loss Drug Emerges From China

Rival GLP-1 Weight-Loss Drug Emerges From China

Dennis Thompson

Jun 24, 2025

3 min read

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

Jun 23, 2025

1 min read

Popular Weight-Loss Drugs Produce Less Weight Loss in Real-World Settings, Study Finds

Popular Weight-Loss Drugs Produce Less Weight Loss in Real-World Settings, Study Finds

Jun 11, 2025

1 min read

Real-World Results For GLP-1 Drugs Underwhelm, Study Says

Real-World Results For GLP-1 Drugs Underwhelm, Study Says

Dennis Thompson

Jun 11, 2025

3 min read

Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition

Prolonged Use of GLP-1 Receptor Agonists May Increase the Risk for a Serious Eye Condition

Jun 06, 2025

1 min read

GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers

GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers

May 30, 2025

1 min read

Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers

Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers

Dennis Thompson

May 28, 2025

3 min read

Read More

www.healthday.com